富国银行下调哈门那评级至“持有”

Core Viewpoint - Wells Fargo downgraded the rating of health insurance company Hamanah from "Outperform" to "Hold," while maintaining the target price at $290 [1] Group 1 - The downgrade reflects a shift in the investment outlook for Hamanah, indicating potential concerns about its future performance [1] - The target price of $290 suggests that Wells Fargo sees limited upside potential from the current trading levels [1]